MC, Á., S, O., G, C., M, C., J, O., P, S., . . . E, M. (2021). Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice. Dove Medical Press.
Style de citation Chicago (17e éd.)MC, Álamo, et al. Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice. Dove Medical Press, 2021.
Style de citation MLA (8e éd.)MC, Álamo, et al. Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice. Dove Medical Press, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.